Acquisition

Fermenta Biotech USA, LLC acquires 52% interest in AGD Nutrition LLC

New Delhi, December 08, 2020: Fermenta Biotech Limited (FBL), India has announced that its wholly owned subsidiary Fermenta Biotech USA LLC (FBU), Wilmington, DE, has acquired a 52% stake in a US-based vitamin company, AGD Nutrition LLC (AGD), headquartered in Nacogdoches, Texas. The deal would combine the expertise of both companies and result in synergies that will bring in greater operational capabilities to enhance FBL’s footprint in the US market. 

This collaboration will couple FBL’s competence in manufacturing and customer-driven innovation with AGD’s distribution strength in the US, which is a geography that commands a significant share of the global human and animal nutrition market. AGD, an established player in the vitamin market since 2002, will be instrumental in paving the way for FBL to gain greater customer access through its deep understanding of the North American market. 

Commenting on the development, Mr Krishna Datla, Managing Director, Fermenta Biotech Ltd. said: 

“AGD has been our valued partner for many years, and this strategic investment intensifies our long-standing mutually-beneficial relationship in the North American market. We are confident that this alliance will result in increased customer proximity and reaffirm our commitment towards our clientele as a sustainable partner for their nutritional ingredients’ requirements. We look forward to the opportunities that will emerge from this partnership in way of stronger relationships with customers in the fields of animal nutrition, pharmaceuticals and dietary supplements.” 

Mr J. Bradley Reynolds, Director, AGD Nutrition LLC commented:

“This will be a landmark alliance, where FBL’s technologies and quality product offerings will complement AGD’s relationships with its robust customer base. It marks a milestone in our efforts to achieve sustainable as well as profitable growth and underlines our focus to boost product delivery in the nutritional ingredients segment.”

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Dr. Agarwals Eye Hospital Supports Nutritional Well-being of Children with Vehicle Donation to Akshaya Patra Foundation in Hubli

Hubli, May 20, 2024: In a significant move to support child nutrition through effective logistical contributions,…

2 days ago

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

4 days ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

6 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

7 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

1 week ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420